Company Performance Metrics
Serox develops biotechnology diagnostics that use photonics and machine learning to support clinical decision making. The company focuses on non-invasive, low-cost, point-of-care testing that processes urine samples to identify biochemical patterns linked to disease. Its platform integrates surface enhanced Raman spectroscopy with data models to
provide rapid desktop analysis for conditions such as bladder, prostate, and kidney cancers. Serox designs its diagnostic workflow to reduce reliance on invasive and expensive procedures such as biopsies, cystoscopies, phlebotomies, and advanced imaging. The company also develops specialized models that can be tailored to specific regional, ethnic, and demographic populations. Its approach supports healthcare providers seeking scalable, personalized, data-centric diagnostic pathways.
